Table of Contents

Articles

Select this article

Proceedings of the International Congress on Hormonal Steroids and Hormones and Cancer. 21-25 October 2002, Fukuoka, Japan.
Endocr Relat Cancer 10 (2) 109-345, doi:10.1677/erc.0.0100109
- Abstract
- Full Text (PDF)
Select this article
- R J Santen,
- R X Song,
- Z Zhang,
- R Kumar,
- M-H Jeng,
- S Masamura,
- W Yue,
- and L Berstein
Adaptive hypersensitivity to estrogen: mechanism for superiority of aromatase inhibitors over selective estrogen receptor modulators for breast cancer treatment and prevention.
Endocr Relat Cancer 10 (2) 111-30, doi:10.1677/erc.0.0100111
- Abstract
- Full Text (PDF)
Select this article
- D M Peehl and
- D Feldman
The role of vitamin D and retinoids in controlling prostate cancer progression.
Endocr Relat Cancer 10 (2) 131-40, doi:10.1677/erc.0.0100131
- Abstract
- Full Text (PDF)
Select this article
- J A Men√©ndez,
- I Mehmi,
- D W Griggs,
- and R Lupu
The angiogenic factor CYR61 in breast cancer: molecular pathology and therapeutic perspectives.
Endocr Relat Cancer 10 (2) 141-52, doi:10.1677/erc.0.0100141
- Abstract
- Full Text (PDF)
Select this article
- E J S√°nchez-Barcel√≥,
- S Cos,
- R Fern√°ndez,
- and M D Mediavilla
Melatonin and mammary cancer: a short review.
Endocr Relat Cancer 10 (2) 153-9, doi:10.1677/erc.0.0100153
- Abstract
- Full Text (PDF)
Select this article
- R M Moretti,
- M Monagnani Marelli,
- J C van Groeninghen,
- M Motta,
- and P Limonta
Inhibitory activity of luteinizing hormone-releasing hormone on tumor growth and progression.
Endocr Relat Cancer 10 (2) 161-7, doi:10.1677/erc.0.0100161
- Abstract
- Full Text (PDF)
Select this article
- S K Kang,
- K-C Choi,
- H-S Yang,
- and P C K Leung
Potential role of gonadotrophin-releasing hormone (GnRH)-I and GnRH-II in the ovary and ovarian cancer.
Endocr Relat Cancer 10 (2) 169-77, doi:10.1677/erc.0.0100169
- Abstract
- Full Text (PDF)
Select this article
- S F Doisneau-Sixou,
- C M Sergio,
- J S Carroll,
- R Hui,
- E A Musgrove,
- and R L Sutherland
Estrogen and antiestrogen regulation of cell cycle progression in breast cancer cells.
Endocr Relat Cancer 10 (2) 179-86, doi:10.1677/erc.0.0100179
- Abstract
- Full Text (PDF)
Select this article
- G P Risbridger,
- J J Bianco,
- S J Ellem,
- and S J McPherson
Oestrogens and prostate cancer.
Endocr Relat Cancer 10 (2) 187-91, doi:10.1677/erc.0.0100187
- Abstract
- Full Text (PDF)
Select this article
- S-I Hayashi,
- H Eguchi,
- K Tanimoto,
- T Yoshida,
- Y Omoto,
- A Inoue,
- N Yoshida,
- and Y Yamaguchi
The expression and function of estrogen receptor alpha and beta in human breast cancer and its clinical application.
Endocr Relat Cancer 10 (2) 193-202, doi:10.1677/erc.0.0100193
- Abstract
- Full Text (PDF)
Select this article
- N Terakawa,
- Y Kanamori,
- and S Yoshida
Loss of PTEN expression followed by Akt phosphorylation is a poor prognostic factor for patients with endometrial cancer.
Endocr Relat Cancer 10 (2) 203-8, doi:10.1677/erc.0.0100203
- Abstract
- Full Text (PDF)
Select this article
- H Suzuki,
- T Ueda,
- T Ichikawa,
- and H Ito
Androgen receptor involvement in the progression of prostate cancer.
Endocr Relat Cancer 10 (2) 209-16, doi:10.1677/erc.0.0100209
- Abstract
- Full Text (PDF)
Select this article
- W-D Han,
- Y-M Mu,
- X-C Lu,
- Z-M Xu,
- X-J Li,
- L Yu,
- H-J Song,
- M Li,
- J-M Lu,
- Y-L Zhao,
- and C-Y Pan
Up-regulation of LRP16 mRNA by 17beta-estradiol through activation of estrogen receptor alpha (ERalpha), but not ERbeta, and promotion of human breast cancer MCF-7 cell proliferation: a preliminary report.
Endocr Relat Cancer 10 (2) 217-24, doi:10.1677/erc.0.0100217
- Abstract
- Full Text (PDF)
Select this article
- J Simard,
- M Dumont,
- D Labuda,
- D Sinnett,
- C Meloche,
- M El-Alfy,
- L Berger,
- E Lees,
- F Labrie,
- and S V Tavtigian
Prostate cancer susceptibility genes: lessons learned and challenges posed.
Endocr Relat Cancer 10 (2) 225-59, doi:10.1677/erc.0.0100225
- Abstract
- Full Text (PDF)
Select this article
- H Rochefort,
- M Glondu,
- M E Sahla,
- N Platet,
- and M Garcia
How to target estrogen receptor-negative breast cancer?
Endocr Relat Cancer 10 (2) 261-6, doi:10.1677/erc.0.0100261
- Abstract
- Full Text (PDF)
Select this article
- L M Berstein,
- H Zheng,
- W Yue,
- J-P Wang,
- A E Lykkesfeldt,
- F Naftolin,
- H Harada,
- M Shanabrough,
- and R J Santen
New approaches to the understanding of tamoxifen action and resistance.
Endocr Relat Cancer 10 (2) 267-77, doi:10.1677/erc.0.0100267
- Abstract
- Full Text (PDF)
Select this article
- J Bogdanos,
- D Karamanolakis,
- R Tenta,
- A Tsintavis,
- C Milathianakis,
- C Mitsiades,
- and M Koutsilieris
Endocrine/paracrine/autocrine survival factor activity of bone microenvironment participates in the development of androgen ablation and chemotherapy refractoriness of prostate cancer metastasis in skeleton.
Endocr Relat Cancer 10 (2) 279-89, doi:10.1677/erc.0.0100279
- Abstract
- Full Text (PDF)
Select this article
- G Emons,
- C Gr√ºndker,
- A R G√ºnthert,
- S Westphalen,
- J Kavanagh,
- and C Verschraegen
GnRH antagonists in the treatment of gynecological and breast cancers.
Endocr Relat Cancer 10 (2) 291-9, doi:10.1677/erc.0.0100291
- Abstract
- Full Text (PDF)
Select this article
- L Sfondrini,
- A Balsari,
- and S M√©nard
Innate immunity in breast carcinoma.
Endocr Relat Cancer 10 (2) 301-8, doi:10.1677/erc.0.0100301
- Abstract
- Full Text (PDF)
Select this article
- N Garcia de la Torre,
- J A H Wass,
- and H E Turner
Parathyroid adenomas and cardiovascular risk.
Endocr Relat Cancer 10 (2) 309-22, doi:10.1677/erc.0.0100309
- Abstract
- Full Text (PDF)
Select this article
- W E Farrell and
- R N Clayton
Epigenetic change in pituitary tumorigenesis.
Endocr Relat Cancer 10 (2) 323-30, doi:10.1677/erc.0.0100323
- Abstract
- Full Text (PDF)
Select this article
- I H L Hamelers and
- P H Steenbergh
Interactions between estrogen and insulin-like growth factor signaling pathways in human breast tumor cells.
Endocr Relat Cancer 10 (2) 331-45, doi:10.1677/erc.0.0100331
- Abstract
- Full Text (PDF)

Endocrine-Related Cancer

Articles

Proceedings of the International Congress on Hormonal Steroids and Hormones and Cancer. 21-25 October 2002, Fukuoka, Japan.

Adaptive hypersensitivity to estrogen: mechanism for superiority of aromatase inhibitors over selective estrogen receptor modulators for breast cancer treatment and prevention.

The role of vitamin D and retinoids in controlling prostate cancer progression.

The angiogenic factor CYR61 in breast cancer: molecular pathology and therapeutic perspectives.

Melatonin and mammary cancer: a short review.

Inhibitory activity of luteinizing hormone-releasing hormone on tumor growth and progression.

Potential role of gonadotrophin-releasing hormone (GnRH)-I and GnRH-II in the ovary and ovarian cancer.

Estrogen and antiestrogen regulation of cell cycle progression in breast cancer cells.

Oestrogens and prostate cancer.

The expression and function of estrogen receptor alpha and beta in human breast cancer and its clinical application.

Loss of PTEN expression followed by Akt phosphorylation is a poor prognostic factor for patients with endometrial cancer.

Androgen receptor involvement in the progression of prostate cancer.

Up-regulation of LRP16 mRNA by 17beta-estradiol through activation of estrogen receptor alpha (ERalpha), but not ERbeta, and promotion of human breast cancer MCF-7 cell proliferation: a preliminary report.

Prostate cancer susceptibility genes: lessons learned and challenges posed.

How to target estrogen receptor-negative breast cancer?

New approaches to the understanding of tamoxifen action and resistance.

Endocrine/paracrine/autocrine survival factor activity of bone microenvironment participates in the development of androgen ablation and chemotherapy refractoriness of prostate cancer metastasis in skeleton.

GnRH antagonists in the treatment of gynecological and breast cancers.

Innate immunity in breast carcinoma.

Parathyroid adenomas and cardiovascular risk.

Epigenetic change in pituitary tumorigenesis.

Interactions between estrogen and insulin-like growth factor signaling pathways in human breast tumor cells.

This Issue

New Articles: issue in progress

Most

Viewed

Cited